| Business Summary | | Millipore
Corporation
and
its
subsidiaries
are
engaged
primarily
in
the
development,
manufacture
and
sale
of
products
that
are
based
on
separations
technology
and
are
used
for
the
analysis,
identification
and
purification
of
liquids
and
gases.
Millipore
also
generates
revenues
from
the
manufacture
and
sale
of
products
based
on
electromechanical
and
pressure
differential
technologies
to
monitor
and
control
critical
aspects
of
the
manufacturing
process
for
integrated
circuits.
Millipore
is
an
integrated
multinational
manufacturer
and
markets
its
products
throughout
the
world.
The
principal
customer
groups
to
which
the
Company's
products
are
sold
include
pharmaceutical
companies,
biotechnology
companies,
food
and
beverage
companies,
university
and
government,
life
science
research
companies,
laboratories
and
research
institutes,
as
well
as
semiconductor
fabrication
companies
and
original
equipment
manufacturers
and
material
suppliers
to
the
semiconductor
industry. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | MIL
is
engaged
primarily
in
the
development,
manufacture
and
sale
of
products
which
are
based
on
separations
technology
and
which
are
used
for
the
analysis,
identification,
monitoring
and
purification
of
liquids
and
gasses.
For
the
six
months
ended
6/30/01,
revenues
rose
10%
to
$330.5
million.
Net
income
from
disc.
operations
fell
19%
to
$27.6
million.
Results
reflect
growth
in
both
the
Microelectronics
and
BioScience
segments,
offset
by
$18
million
in
restruct.
charges. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| William Zadel, 57 Chairman | $1.8M | -- | Francis Lunger, 55 Pres,
CEO, Director | 1.9M | $206K | Kathleen Allen, 45 CFO,
VP, Treasurer | -- | -- | Jeffrey Rudin, 49 VP
and Gen. Counsel | -- | -- | John Lary, 55 VP | -- | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|